Search Within

Andreas Rimner

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (7)
Groups
  1. Department of Medicine (19)
  2. Hematologic Malignancies, Division of (19)
  3. Radiation Oncology, Department of (15)
  4. Epidemiology and Biostatistics (13)
  5. Solid Tumor Oncology Division (13)
  6. Biostatistics Service (12)

More Groups

People
  1. Daniel Gomez (9)
  2. Narek Shaverdian (8)
  3. Zhigang Zhang (8)
  4. Abraham Wu (6)
  5. Emily Lebow (6)
  6. Jamie Chaft (6)

More People

Years
  1. 2023 (4)
  2. 2022 (5)
  3. 2021 (1)
  4. 2019 (2)
  5. 2017 (3)
  6. 2010 (2)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (5)
  2. Clinical Cancer Research (3)
  3. Journal of Thoracic Oncology (2)
  4. Cancer Immunology Research (1)
  5. EJC Supplements (1)
  6. Haematologica (1)

More Publications

Publishers
  1. Elsevier Inc. (8)
  2. American Association for Cancer Research (4)
  3. Nature Publishing Group (2)
  4. American Medical Association (1)
  5. Biomed Central Ltd (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (19)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence and preliminary validation of screening criteria to identify carriers of germline BAP1 mutations
    Journal Article

    Zauderer, M. G.; Jayakumaran, G.; DuBoff, M.; Zhang, L.; Francis, J. H.; Abramson, D. H.; Cercek, A.; Nash, G. M.; Shoushtari, A.; Chapman, P.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • BCMA-targeted CAR T-cell therapy plus radiotherapy for the treatment of refractory myeloma reveals potential synergy
    Journal Article

    Smith, E. L.; Mailankody, S.; Staehr, M.; Wang, X.; Senechal, B.; Purdon, T. J.; Daniyan, A. F.; Geyer, M. B.; Goldberg, A. D.; Mead, E.; more...
    Cancer Immunology Research (2019)

    Fulltext@MSK | Save
  • A randomized phase II trial of adjuvant galinpepimut-S, WT-1 analogue peptide vaccine, after multimodality therapy for patients with malignant pleural mesothelioma
    Journal Article

    Zauderer, M. G.; Tsao, A. S.; Dao, T.; Panageas, K.; Lai, W. V.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; Ginsberg, M. S.; Gomez, D.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: Expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1
    Journal Article

    Eguchi, T.; Kadota, K.; Mayor, M.; Zauderer, M. G.; Rimner, A.; Rusch, V. W.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Accelerated total lymphoid irradiation-containing salvage regimen for patients with refractory and relapsed Hodgkin lymphoma: 20 years of experience
    Journal Article

    Rimner, A.; Lovie, S.; Hsu, M.; Chelius, M.; Zhang, Z.; Chau, K.; Moskowitz, A. J.; Matasar, M.; Moskowitz, C. H.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Long term outcome of high-dose salvage therapy for patients with early stage Hodgkin lymphoma (HL) who failed initial treatment with combined modality treatment or chemotherapy alone
    Meeting Abstract

    Rimner, A.; Lovie, S.; Bonner, P.; Hsu, M.; Zhang, Z.; Moskowitz, C. H.; Yahalom, J.
    Haematologica (2010)

    Fulltext@MSK | Save
  • Long-term outcome of high-dose salvage chemoradiation for patients with early stage Hodgkin Lymphoma (HL) who failed initial treatment with combined modality treatment (CMT) or chemotherapy alone (C)
    Meeting Abstract

    Rimner, A.; Lovie, S.; Bonner, P.; Hsu, M.; Zhang, Z.; Moskowitz, C. H.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2010)

    Fulltext@MSK | Save
  • Accelerated total lymphoid irradiation (TLI) as an integral component of high-dose therapy (HDT) salvage regimen for patients with refractory and relapsed Hodgkin lymphoma (HL): 20 years of experience with 186 patients
    Meeting Abstract

    Rimner, A.; Bonner, P.; Gonzales, A. M. R.; Hsu, M.; Zhang, Z.; Moskowitz, C. H.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2009)

    Fulltext@MSK | Save
  • Accelerated total lymphoid irradiation (TLI)-containing salvage regimen for patients with refractory and relapsed Hodgkin lymphoma (HL): 20 years outcome with multivariate analysis
    Meeting Abstract

    Rimner, A.; Bonner, P.; Gonzales, A. M. R.; Hsu, M.; Zhang, Z.; Moskowitz, C. H.; Yahalom, J.
    EJC Supplements (2009)

    Fulltext@MSK | Save